Article

How Does Sleep Impact Cancer Survival?

Duration of sleep and snoring may play a role in survival outcomes.

Duration of sleep and snoring may play a role in survival outcomes.

Specialty pharmacists counseling cancer patients need to make sure these individuals are getting some quality rest, a recent study suggests.

The study, conducted by the American Academy of Sleep Medicine, indicated that short pre-diagnostic sleep duration and frequent snoring were associated with significantly worse cancer survival. In narrowing down by cancer type, limited sleep duration and snoring were linked with significantly worse breast cancer survival outcomes.

The study included 21,230 women diagnosed with a primary invasive cancer.

The patients submitted data on several sleep attributes at study baseline, including sleep duration, snoring, and insomnia ratings. The data was adjusted for age, study arm, cancer site, marital status, income, smoking, physical activity, and duration between baseline data collection and cancer diagnosis.

"Our results suggest that sleep duration is important for breast cancer survival, particularly in women who snore," lead author Amanda Phipps said in a press release.

Related Videos
Anthony Perissinotti, PharmD, BCOP, discusses unmet needs and trends in managing chronic lymphocytic leukemia (CLL), with an emphasis on the pivotal role pharmacists play in supporting medication adherence and treatment decisions.
Image Credit: © alenamozhjer - stock.adobe.com
pharmacogenetics testing, adverse drug events, personalized medicine, FDA collaboration, USP partnership, health equity, clinical decision support, laboratory challenges, study design, education, precision medicine, stakeholder perspectives, public comment, Texas Medical Center, DNA double helix
pharmacogenetics challenges, inter-organizational collaboration, dpyd genotype, NCCN guidelines, meta census platform, evidence submission, consensus statements, clinical implementation, pharmacotherapy improvement, collaborative research, pharmacist role, pharmacokinetics focus, clinical topics, genotype-guided therapy, critical thought
Image Credit: © Andrey Popov - stock.adobe.com
Image Credit: © peopleimages.com - stock.adobe.com
TRUST-I and TRUST-II Trials Show Promising Results for Taletrectinib in ROS1+ NSCLC
World Standards Week 2024: US Pharmacopeia’s Achievements and Future Focus in Pharmacy Standards